Kathleen E Corey (Kathleen Corey)

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 15

Top Topics

Coronary Artery Bypass Grafting

Ankylosing Spondylitis

Cardiovascular Disease

Top Venues

Hepatology communications

Digestive diseases and sciences

Hepatology (Baltimore, Md.)

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan G Stine, Michelle T Long, Kathleen E Corey, Robert E Sallis, Alina M Allen, Matthew James Armstrong, David E Conroy, Daniel J Cuthbertson, Andres Duarte-Rojo, Kate Hallsworth, Ingrid J Hickman, Matthew Robert Kappus, Shelley Elizabeth Keating, Christopher J A Pugh, Yaron Rotman, Tracey G Simon, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Kathryn H Schmitz
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology communications 7 (4) (2023)
Oluwafemi Balogun, Jeffrey Y Wang, Emad S Shaikh, Karine Liu, Stefania Stoyanova, Zoe N Memel, Hayley Schultz, Lisa Mun, Jack Bertman, Cheryl A Rogen, Maryam K Ibrahim, Madeline Berschback, Eugenia Uche-Anya, Robert Wilechansky, Tracey G Simon, Kathleen E Corey
Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD. Hepatology communications 7 (11) (2023)
Jonathan G Stine, Michelle T Long, Kathleen E Corey, Robert E Sallis, Alina M Allen, Matthew James Armstrong, David E Conroy, Daniel J Cuthbertson, Andres Duarte-Rojo, Kate Hallsworth, Ingrid J Hickman, Matthew Robert Kappus, Shelley Elizabeth Keating, Christopher J A Pugh, Yaron Rotman, Tracey G Simon, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Kathryn H Schmitz
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology communications 7 (4) (2023)
Jonathan G Stine, Michelle T Long, Kathleen E Corey, Robert E Sallis, Alina M Allen, Matthew James Armstrong, David E Conroy, Daniel J Cuthbertson, Andres Duarte-Rojo, Kate Hallsworth, Ingrid J Hickman, Matthew Robert Kappus, Shelley Elizabeth Keating, Christopher J A Pugh, Yaron Rotman, Tracey G Simon, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Kathryn H Schmitz
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology communications 7 (4) (2023)
Myung-Ho Kim, Mi-Young Kim, Shadi Salloum, Tongqi Qian, Lai Ping Wong, Min Xu, Yoojin Lee, Stuti G Shroff, Ruslan I Sadreyev, Kathleen E Corey, Thomas F Baumert, Yujin Hoshida, Raymond T Chung
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature. Hepatology communications 6 (9) (2022)
Rish K Pai, Vipul Jairath, Malcolm Hogan, Guangyong Zou, Oyedele A Adeyi, Quentin Mark Anstee, Bashar A Aqel, Cynthia Behling, Elizabeth J Carey, Andrew D Clouston, Kathleen E Corey, Brian G Feagan, David E Kleiner, Christopher Ma, Stefanie C McFarlane, Mazen Noureddin, Vlad Ratziu, Mark A Valasek, Zobair M Younossi, Stephen A Harrison, Stephen Caldwell
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score. Hepatology (Baltimore, Md.) 76 (4) (2022)
Júlia Karády, Maros Ferencik, Thomas Mayrhofer, Nandini M Meyersohn, Daniel O Bittner, Pedro V Staziaki, Balint Szilveszter, Travis R Hallett, Michael T Lu, Stefan B Puchner, Tracey G Simon, Borek Foldyna, Geoffrey S Ginsburg, Robert W McGarrah, Deepak Voora, Svati H Shah, Pamela S Douglas, Udo Hoffmann, Kathleen E Corey
Risk factors for cardiovascular disease among individuals with hepatic steatosis. Hepatology communications 6 (12) (2022)
Michelle T Long, Xiaoyu Zhang, Hanfei Xu, Ching-Ti Liu, Kathleen E Corey, Raymond T Chung, Stephen Caldwell, Emelia J Benjamin
Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study. Hepatology (Baltimore, Md.) 73 (2) (2021)
Jacqueline B Henson, Michael Roden, Giovanni Targher, Kathleen E Corey
Is Nonalcoholic Fatty Liver Disease Not a Risk Factor for Cardiovascular Disease: Not Yet Time for a Change of Heart. Hepatology (Baltimore, Md.) 71 (5) (2021)
Jacqueline B Henson, Tracey G Simon, Alyson Kaplan, Stephanie Osganian, Ricard Masia, Kathleen E Corey
Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 51 (7) (2020)
Jacqueline B Henson, Kathleen E Corey
Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply. Alimentary pharmacology & therapeutics 51 (10) (2020)
Zoe N Memel, Ashwini Arvind, Oluwatoba Moninuola, Lisa Philpotts, Raymond T Chung, Kathleen E Corey, Tracey G Simon
Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Hepatology communications 5 (1) (2020)
Kathleen E Corey, Laura A Wilson, Akif Altinbas, Katherine P Yates, David E Kleiner, Raymond T Chung, Ronald M Krauss, Naga P Chalasani, null null
Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial. Alimentary pharmacology & therapeutics 49 (9) (2019)
Kathleen E Corey, Mary E Rinella
Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis. Digestive diseases and sciences 61 (5) (2016)
Kathleen E Corey, Matthew J Klebanoff, Angela C Tramontano, Raymond T Chung, Chin Hur
Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis. Digestive diseases and sciences 61 (7) (2016)
Kathleen E Corey, Uri Kartoun, Hui Zheng, Stanley Y Shaw
Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record. Digestive diseases and sciences 61 (3) (2015)